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Kathryn B. Garber1,*Gene-Expression Patterns Predict MS
People who develop multiple sclerosis (MS) ﬁrst present
with a clinically isolated syndrome (CIS), which is a single
neurologic episode compatible with MS that is caused by
inﬂammation and demyelination in the central nervous
system. Although approximately one-third of people
with CIS progress to diagnosable MS within a year, others
never go on to have MS. The trick is ﬁguring out who is
at the most risk. Physicians use radiographic methods to
make predictions, but these methods are not extremely ac-
curate, so Corvol et al. explored molecular methods of risk
stratiﬁcation. In CD4þ lymphocytes of people with CIS,
they identiﬁed gene expression signatures that are charac-
terized by downregulation of proinﬂammatory genes. Not
only can the signatures be used to distinguish people
newly diagnosed with CIS from controls, they also high-
light a group of people with CIS who are at much higher
risk of conversion to MS and at a faster rate than the rest
of the CIS group. Beyond these risk predictions, this work
could also help us understand how MS develops. One of
the most striking changes in gene expression in the high-
risk CIS group is the downregulation of TOB1, which
encodes a repressor of T cell proliferation. Altered TOB1
expression could be an early defect that is pivotal in the
development of the devastating effects of this autoimmune
disorder.
Corvol et al. PNAS. Published online August 8, 2008.
10.1073/pnas.0805065105
Exploring West Nile
Since its appearance in the United States in 1999 and sub-
sequent spread, West Nile virus has become an infamous
pathogen across the country. What many may not know
is that serious disease occurs in less than 1% of people in-
fected with the virus., and few factors governing suscepti-
bility to West Nile infection and disease are known.
Krishnan et al. approached this problem with a forward
genetics screen using siRNAs from across the genome to
study West Nile infection in cell culture. Among the host
susceptibility factors are genes involved in intracellular
protein trafﬁcking, endoplasmic reticulum associated pro-
tein degradation, immunity, and the transport of ions and
biomolecules, whereas the major factor involved in resis-
tance to West Nile virus is the plasma membrane trans-
porter of monocarboxylic acids MCT4. These genes and
the pathways to which they belong thus become key tothe understanding of virus-host cell interactions. It is
also plausible that variation in some of the susceptibility
and resistance genes could be associated with the likeli-
hood of serious West Nile disease in individuals.
Krishnan et al. Nature. Published online August 6, 2008.
10.1038/nature07207
It Sure Beats a Colonoscopy
One way to monitor latent infections like HIV is to moni-
tor the level of viral DNA in the body. If the invading cells
happen to be the body’s own cells gone awry, as in cancer,
monitoring asymptomatic disease becomes trickier be-
cause of the necessity to distinguish tumor DNA from
the rest of the DNA in the body. The existence of common
mutations in certain cancers has made it possible to detect
tumor DNA in plasma, and it is now possible to quantify
the often minute quantities of mutant DNA in blood sam-
ples. Diehl et al. believe that this technology can be used to
monitor disease in patients undergoing treatment for some
cancers, and they illustrate this using plasma samples from
individuals undergoing treatment for metastatic colorectal
cancer. In comparison to carcinoembryonic antigen—the
standard biomarker currently used to monitor these
patients—circulating tumor DNA (ctDNA) was better able
to predict recurrence of disease in their sample. Subjects
who had ctDNA present in their blood after surgical resec-
tion of their tumors were much more likely to relapse
within one year than were subjects in whom ctDNA could
not be detected. As more data are collected on the oscilla-
tions of ctDNA during treatment and follow-up, this may
become a useful and noninvasive biomarker to inﬂuence
management strategies for cancer patients.
Diehl et al. Nature Medicine. Published online July 31, 2008.
10.1038/nm.1789
Mouse Mutants Yield Clues to Diamond-Blackfan
Anemia
What do mouse ear color and red blood cell production
have in common? In studies of two mouse mutants with
pigmentary abnormalities, McGowan et al. found that de-
fects in ribosomal proteins, which also cause Diamond-
Blackfan anemia (DBA), are responsible for an epidermal
melanocytosis that increases pigmentation of the foot-
pads, tail, and ears. It is puzzling that defects in ribosome
biogenesis would have such speciﬁc effects in the mouse
mutants and in DBA, which is characterized by a defect1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
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in the production of red blood cells. McGowan et al.
provide evidence that p53 stabilization may be a common
feature of both outcomes but that cell-type speciﬁc path-
ways downstream of this p53 over-activation give rise to
the phenotypes observed. In the case of the pigmentary
abnormalities in mice, p53 activation increases expression
of the Kit ligand, which, in turn, leads to epidermal mela-
nocytosis. At least one of the mouse mutants also has
a lower red blood cell count, which is reminiscent of
DBA. In the bone marrow, these mice exhibit increased
apoptosis of bone marrow progenitor cells, which presum-
ably is triggered by p53 and could play a role in the path-
ogenesis of DBA.
McGowan et al. Nature Genetics 40, 963–970.
Copy-Number Variation and Schizophrenia
Many of the genetic association studies that have been
published over the past few years have been dependent
on the common disease-common variant hypothesis,
which postulates that common genetic variation in the
population contributes to the common disorders that
have a genetic underpinning. However, if the disorder of300 The American Journal of Human Genetics 83, 299–300, Septeminterest reduces the likelihood that an individual will
have children, perhaps the underlying genetic factors are
not likely to be all that common. At least that’s the theory
that led Stefansson et al. to look for rare copy number var-
iations (CNV) that contribute to schizophrenia. They used
a population-based sample of trios and parent-offspring
pairs to identify de novo CNVs and then tested them for
association with schizophrenia in a large case-control sam-
ple. They report three deletions, on chromosomes 1q21.1,
15q11.2, and 15q13.3, that are signiﬁcantly associated
with schizophrenia. The International Schizophrenia Con-
sortium was also interested in rare CNVs that contribute to
schizophrenia. In a publication simultaneous with the
work by Stefansson et al., they independently identiﬁed
the same regions on chromosomes 1q21.1 and 15q13.3
as contributing to schizophrenia. Together, these reports
suggest that rare structural variation may play a role in at
least some cases of schizophrenia.
Stefansson. Nature. Published online July 30, 2008.
10.1038/nature07229
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